Concordare Trials

Concordare Trials is a New York-based clinical research software company that converts static clinical trial protocol documents into a structured, machine-readable format it calls the Clinical Trial Protocol Model (CTPM). Protocols, which the company describes as frequently exceeding 300 pages, are today read and reinterpreted by many separate teams at hospitals, vendors and software groups, each of whom rebuilds the same study logic into calendars, checklists and operational documents. Concordare's stated aim is to make the protocol itself interoperable so that one extraction drives the downstream operational artifacts.

The product ingests study design PDFs through an AI conversion engine (referred to as Apta on the company site, and as the Concordare Suite in press announcements) and produces a protocol-specific CTPM. From that model the platform generates visit-by-visit source documents and procedure worksheets, electronic data capture (EDC) builds including forms, fields and validation/edit-check rules, clinical trial management system (CTMS) configurations such as milestones, site setup and visit schedules, and billing grids/schedules of events and costs. The company states AI is used only for extraction and that every CTPM is reviewed and approved by the customer's team before any output is generated. A February 2026 interview also references a site-facing product called Concordare Opus.

The company positions itself against clinical trial software that manages studies after operational setup has already occurred or that is tied to a single sponsor ecosystem, and says its format is designed to work across any sponsor, site and downstream system so a site can apply it across all of its studies.

Founding story

Sawaged states he started the company after experiencing the problem directly in clinical operations at NYU Langone's Perlmutter Cancer Center, where he observed teams repeatedly rebuilding the same protocol logic across different tools, and concluded the protocol itself should be digital and reusable. He trained in biomedical informatics at NYU, which he describes as where the early foundation for the company was shaped.

Business model

Software sold to clinical research sites as well as sponsors and CROs, with the website offering separate entry paths for sites and for sponsors/CROs. The company describes an enterprise motion involving pilots with tightly scoped success metrics, implementation processes for large institutions, onboarding, security review and training.

Traction

Live pilot deployments including Rutgers University, described as a longtime partner using the platform across multiple teams; implementation processes being finalized with NYU Langone and Memorial Sloan Kettering; the company states it is contracting with additional institutions nationwide. The company claims study activation acceleration of six to eight weeks.

Latest developments

In August 2026 the company announced a funding round led by Surface Ventures with participation from Techstars, Innovation Works, Gaingels and individual investors, to fund product development, team expansion and site partnership growth. The team said it expected to add experienced clinical and product hires and had assembled an advisory bench with clinical development and product experience.